Aoyuan Beauty Valley announced that on December 16, 2025, it received a ruling from the Yangyang Intermediate Court to approve the restructuring plan and terminate the restructuring process. Based on a total share capital of 763 million shares, the company transferred 1,34,278 shares for every 10 shares, for a total increase of 1,025 billion shares. After the transfer, the total share capital increased to 1,787 billion shares. The restructuring investors subscribed for a total of 862 million shares. Due to the obvious difference between the current capital reserve transfer and the general situation, the company plans to adjust the exclusion reference price calculation formula. If the closing price of the company's stock is higher than 3.05 yuan/share on the share registration date, the opening reference price is adjusted according to the adjusted formula; if it is lower or equal, no adjustment is required. The financial adviser believes that the adjustment formula is reasonable, and at the same time indicates the risk of failure to restructure and delisting.

Aoyuan Beauty Valley announced that on December 16, 2025, it received a ruling from the Yangyang Intermediate Court to approve the restructuring plan and terminate the restructuring process. Based on a total share capital of 763 million shares, the company transferred 1,34,278 shares for every 10 shares, for a total increase of 1,025 billion shares. After the transfer, the total share capital increased to 1,787 billion shares. The restructuring investors subscribed for a total of 862 million shares. Due to the obvious difference between the current capital reserve transfer and the general situation, the company plans to adjust the exclusion reference price calculation formula. If the closing price of the company's stock is higher than 3.05 yuan/share on the share registration date, the opening reference price is adjusted according to the adjusted formula; if it is lower or equal, no adjustment is required. The financial adviser believes that the adjustment formula is reasonable, and at the same time indicates the risk of failure to restructure and delisting.